Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of kinase inhibitors for cancer therapy. Its spirocyclic structure with a fluorine substituent enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its rigid framework and ability to mimic peptide motifs. Also utilized in the preparation of bioactive molecules targeting neurological disorders and inflammatory diseases.